Dev

In a special issue of the Cell Press journal Neuron, experts debated the challenges associated with “translational neuroscience,” and the efforts that should be made to commercialize advances made in the laboratory so that patients can benefit from them. Despite…

Using data from old clinical trials, two groups of researchers have found a better way to predict how amyotrophic lateral sclerosis (ALS) progresses in different patients. The winning algorithms—designed by non-ALS experts—outperformed the judgments of a group of ALS clinicians…

The Medical Research Council (MRC) Dementias Research Platform UK (DPUK) is a multi-million pound public-private partnership, developed and led by the MRC, to accelerate progress in, and open up, dementias research. The DPUK’s aims are early detection, improved treatment and ultimately,…

The annual meeting of the American Society of Neuroscience 2014 is taking place on Nov 15-17th in Washington DC, USA. A number of meeting bloggers will be sharing their experiences at the conference. These blogs are only a few of the…

Researchers studying frontotemporal degeneration (FTD) disease, a leading cause of early onset dementia, will receive more than $30 million over the next five years in grants from the National Institutes of Health (NIH). The funding will be used to further…

In the first post on this new online service, Dr Ed Wild and Dr Jeff Carroll talk about the five new clinical trials enrolling now or starting soon for Huntington’s disease. Plus, a detailed discussion of the eagerly-awaited clinical trial…

In the UK, to support clinical and care staff, managers and estates colleagues, the King’s Fund has produced a range of resources to enable hospitals, care homes, primary care premises and specialist housing providers to become more dementia friendly. The…

The 2014 Nobel Prize in Physiology or Medicine has honored three neuroscientists. John O’Keefe, along with May-Britt Moser and Edvard Moser, discovered cells that form a positioning system in the brain — our hard-wired GPS. Those cells mark our position,…

A Small Number of Patients With Fetal-Cell Transplants Are Thriving Two Decades Later. Several patients with Parkinson’s disease who received brain-tissue transplants from fetuses in the early 1990s have needed little or no medicine to treat the disease ever since—an…